PBA

Paradigm Biocapital Advisors’s Keros Therapeutics KROS Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-525,037	Closed	-$30.5M	–	34
2024 Q3	$30.5M	Buy	+525,037	New	+$30.5M	1.03%	27
2023 Q2	–	Sell	-930,752	Closed	-$39.7M	–	32
2023 Q1	$39.7M	Buy	+930,752	New	+$39.7M	3.77%	12